Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release

OBJECTIVE: To evaluate over 108 weeks the effect of phentermine and topiramate extended release (PHEN/TPM ER) treatment on progression to type 2 diabetes and/or cardiometabolic disease in subjects with prediabetes and/or metabolic syndrome (MetS) at baseline. RESEARCH DESIGN AND METHODS: Subanalysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Garvey, W. Timothy, Ryan, Donna H., Henry, Robert, Bohannon, Nancy J.V., Toplak, Hermann, Schwiers, Michael, Troupin, Barbara, Day, Wesley W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Current Concepts of Type 2 Diabetes Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392900/
https://www.ncbi.nlm.nih.gov/pubmed/24103901
http://dx.doi.org/10.2337/dc13-1518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392900/
https://www.ncbi.nlm.nih.gov/pubmed/24103901
http://dx.doi.org/10.2337/dc13-1518

Ejemplares similares